Edition:
India

Cytosorbents Corp (CTSO.OQ)

CTSO.OQ on NASDAQ Stock Exchange Capital Market

7.45USD
18 Jan 2018
Change (% chg)

$0.05 (+0.68%)
Prev Close
$7.40
Open
$7.50
Day's High
$7.50
Day's Low
$7.25
Volume
7,975
Avg. Vol
20,682
52-wk High
$7.90
52-wk Low
$3.35

Latest Key Developments (Source: Significant Developments)

Cytosorbents Sees Q4 2017 Revenue About $4.6 Million
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Cytosorbents Corp ::CYTOSORBENTS PRE-ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 RESULTS AND ISSUES STOCKHOLDER LETTER.SEES Q4 2017 REVENUE ABOUT $4.6 MILLION.SEES FY 2017 REVENUE $15 MILLION.- WITH NEW TAX LAW, AND WITH SUBSTANTIAL FEDERAL NET OPERATING LOSSES "WE WILL NOT PAY FEDERAL INCOME TAX FOR A LONG TIME".  Full Article

U.S. FDA Approves Cytosorbents' Refresh 2 IDE Application With Conditions
Friday, 22 Dec 2017 

Dec 21 (Reuters) - Cytosorbents Corp ::CYTOSORBENTS ACHIEVES KEY MILESTONE WITH FDA APPROVAL OF THE U.S. REFRESH 2 PIVOTAL CARDIAC SURGERY TRIAL IDE APPLICATION.U.S. FDA GRANTED APPROVAL OF REFRESH 2 INVESTIGATIONAL DEVICE EXEMPTION APPLICATION, WITH CONDITIONS.CONDITIONS RELATE TO REQUESTED CLARIFICATIONS, CHANGES TO PATIENT CONSENT FORM & INSTRUCTIONS FOR USE DOCUMENT.  Full Article

Cytosorbents posts Q3 revenue of $3.8 mln
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Cytosorbents Corp :Cytosorbents continues strong trajectory of growth in the third quarter 2017.Total Q3 2017 revenues increased 59% to $3.8 million​.  Full Article

CytoSorbents signs deal with Armaghan Salamat Kish Group to distribute CytoSorb in Iran
Friday, 23 Sep 2016 

CytoSorbents Corp :Has signed an exclusive distribution agreement with Armaghan Salamat Kish Group to distribute CytoSorb in Iran.  Full Article

Cytosorbents achieves fourth consecutive quarter of record Cytosorb sales
Wednesday, 10 Aug 2016 

Cytosorbents Corp : Cytosorbents achieves fourth consecutive quarter of record Cytosorb® sales . Qtrly loss per share $0.12 .Product sales for Q2 2016 were $1.9 million, an increase of approximately 140% over Q2 2015.  Full Article

Cytosorbents teams with Medial and Meditrade to bring CytoSorb to Hungary, Czech Republic, Slovakia, and Poland
Wednesday, 13 Jul 2016 

Cytosorbents Corp :Cytosorbents teams with medial and meditrade to bring Cytosorb to Hungary, Czech Republic, Slovakia, and Poland.  Full Article

CytoSorbents says independent monitoring board recommends continuation of REFRESH I trial
Friday, 27 May 2016 

CytoSorbents Corp : Independent data safety monitoring board recommends continuation of CytoSorbents REFRESH I trial . Independent data safety monitoring board found no safety concerns, recommended continuation of REFRESH I trial without changes .Plans to submit an investigational device exemption application later this year to initiate a pivotal, registration REFRESH 2 trial.  Full Article

Cytosorbents says total revenue for Q1 was $1.8 million
Tuesday, 10 May 2016 

Cytosorbents Corp : Says total revenue for Q1 of 2016 was $1.8 million, which includes both product sales and grant revenue .Says product gross margin for Q1 2016 was approximately 62% compared to approximately 59% for Q1 2015.  Full Article

BRIEF-Cytosorbents Sees Q4 2017 Revenue About $4.6 Million

* CYTOSORBENTS PRE-ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 RESULTS AND ISSUES STOCKHOLDER LETTER